ReviewMolecular medicine (Cambridge, Mass.)2022

Efficacy of the monocarbonyl curcumin analog C66 in the reduction of diabetes-associated cardiovascular and kidney complications.

Mitko Mladenov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.